Celltrion

This study is testing whether a new psoriasis medication called CT-P55 works as well as an already approved drug called Cosentyx. Researchers are comparing both treatments in 153 people with moderate to severe plaque psoriasis. The goal is to see which treatment better reduces sk…

This study is testing if adding a medication called pioglitazone helps adults with type 2 diabetes who still have high blood sugar despite taking two common drugs (metformin and empagliflozin). Researchers will compare pioglitazone to a placebo (dummy pill) in about 580 people to…

This early-stage study aims to see if a new, potentially cheaper version of the drug Taltz (called CT-P52) behaves the same way in the body as the original. It involves 218 healthy adults who will receive a single dose of either drug. Researchers will measure drug levels in the b…